178 related articles for article (PubMed ID: 7536681)
41. The potential role of granulocyte-macrophage colony stimulating factor (GM-CSF) in cancer chemotherapy.
Cebon JS; Morstyn G
Cancer Surv; 1990; 9(1):131-55. PubMed ID: 2276111
[TBL] [Abstract][Full Text] [Related]
42. IFN-gamma enhances sensitivity of human macrophages to extracellular ATP-mediated lysis.
Blanchard DK; McMillen S; Djeu JY
J Immunol; 1991 Oct; 147(8):2579-85. PubMed ID: 1918978
[TBL] [Abstract][Full Text] [Related]
43. Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor.
Chachoua A; Oratz R; Hoogmoed R; Caron D; Peace D; Liebes L; Blum RH; Vilcek J
J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):217-24. PubMed ID: 8032545
[TBL] [Abstract][Full Text] [Related]
44. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
Wright SC; Jewett A; Mitsuyasu R; Bonavida B
J Immunol; 1988 Jul; 141(1):99-104. PubMed ID: 3132506
[TBL] [Abstract][Full Text] [Related]
45. Priming of neutrophil and monocyte activation in human immunodeficiency virus infection. Comparison of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interferon-gamma.
Meyer CN; Nielsen H
APMIS; 1996 Sep; 104(9):640-6. PubMed ID: 8972688
[TBL] [Abstract][Full Text] [Related]
46. Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes.
Chantry D; Turner M; Brennan F; Kingsbury A; Feldmann M
Cytokine; 1990 Jan; 2(1):60-7. PubMed ID: 2129500
[TBL] [Abstract][Full Text] [Related]
47. Monocyte-mediated killing of human leukaemia is enhanced by administration of granulocyte-macrophage colony stimulating factor following chemotherapy.
Williams MA; Newland AC; Kelsey SM
Br J Haematol; 1997 Sep; 98(4):960-8. PubMed ID: 9326196
[TBL] [Abstract][Full Text] [Related]
48. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
[TBL] [Abstract][Full Text] [Related]
49. Expression of messenger RNA for GM-CSF by blood mononuclear cells after allogeneic bone marrow transplantation.
Atkinson K; Altavilla V; Cooley M
Behring Inst Mitt; 1988 Aug; (83):330-4. PubMed ID: 3071349
[TBL] [Abstract][Full Text] [Related]
50. T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro.
Herrmann F; Cannistra SA; Griffin JD
J Immunol; 1986 Apr; 136(8):2856-61. PubMed ID: 3082974
[TBL] [Abstract][Full Text] [Related]
51. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages.
Bernasconi S; Matteucci C; Sironi M; Conni M; Colotta F; Mosca M; Colombo N; Bonazzi C; Landoni F; Corbetta G
Int J Cancer; 1995 Jan; 60(3):300-7. PubMed ID: 7829234
[TBL] [Abstract][Full Text] [Related]
52. In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor (RhGM-CSF) on polymorphonuclear cell (PMN) and monocyte (MO) functional capacities in ovarian cancer patients versus human volunteers.
Altamura M; Geronimo MG; Pepe M; Lella P; Nappi L; Loizzi P; Forte M; Marsilio M; Piazzolla G; Antonaci S; Jirillo E
Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):437-49. PubMed ID: 9436044
[TBL] [Abstract][Full Text] [Related]
53. Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo.
Aman MJ; Stockdreher K; Thews A; Kienast K; Aulitzky WE; Färber L; Haus U; Koci B; Huber C; Peschel C
Ann Hematol; 1996 Nov; 73(5):231-8. PubMed ID: 8959941
[TBL] [Abstract][Full Text] [Related]
54. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
55. [Human monocytic colony-stimulating factor].
Motoyoshi K
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3531-6. PubMed ID: 2684018
[TBL] [Abstract][Full Text] [Related]
56. Effect of granulocyte-macrophage colony-stimulating factor treatment on phenotype, cytokine release and cytotoxicity of circulating blood monocytes and monocyte-derived macrophages.
Hennemann B; Kreutz M; Rehm A; Andreesen R
Br J Haematol; 1998 Sep; 102(5):1197-203. PubMed ID: 9753045
[TBL] [Abstract][Full Text] [Related]
57. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G; Germenis A
Cytokine; 2002 Jun; 18(5):260-5. PubMed ID: 12161101
[TBL] [Abstract][Full Text] [Related]
58. Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets.
Williams MA; Newland AC; Kelsey SM
Leuk Res; 2000 Apr; 24(4):317-30. PubMed ID: 10713329
[TBL] [Abstract][Full Text] [Related]
59. [Colony stimulating factor].
Takaku F
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3550-3. PubMed ID: 2817907
[TBL] [Abstract][Full Text] [Related]
60. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
